BridgeBio Pharma (BBIO) EPS (Basic) (2018 - 2026)
BridgeBio Pharma (BBIO) posted EPS (Basic) of -$0.84 for Q1 2026, up 16.37% sequentially from -$1.01 in Q4 2025, and up 4.35% YoY from -$0.81 in Q1 2025.
Powered by 
Analysis
BridgeBio Pharma (BBIO) EPS (Basic) (2018 - 2026) Analysis & Trends
BridgeBio Pharma has reported EPS (Basic) for 9 years, with the latest figure at -$0.84 in Q1 2026.
- Quarterly EPS (Basic) rose 4.35% year-over-year to -$0.84 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.7 (down 5.45% YoY) and the FY2025 annual result came in at -$3.78, down 31.46% from the prior year.
- EPS (Basic) climbed to -$0.84 in Q1 2026 per BBIO's latest filing, from -$1.01 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.07 in Q2 2022 and troughed at -$1.42 in Q4 2024.
- A 5-year average of -$0.87 and a median of -$0.93 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) soared 89.77% in 2022, then plunged 1363.84% in 2023.
- Over 5 years, EPS (Basic) stood at -$0.93 in 2022, then decreased by 10.71% to -$1.03 in 2023, then slumped by 37.9% to -$1.42 in 2024, then increased by 29.31% to -$1.01 in 2025, then advanced by 16.37% to -$0.84 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.84, -$1.01, and -$0.95 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | BridgeBio Pharma | 14.65 Bn | 13.93 Bn | 228.63 Mn | -0.78 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.78 |
| Mar 31, 2026 | -0.84 |
| Dec 31, 2025 | -1.01 |
| Sep 30, 2025 | -0.95 |
| Jun 30, 2025 | -0.95 |
| Mar 31, 2025 | -0.88 |
| Dec 31, 2024 | -1.42 |
| Sep 30, 2024 | -0.86 |
| Jun 30, 2024 | -0.39 |
| Mar 31, 2024 | -0.20 |
| Dec 31, 2023 | -1.03 |
| Sep 30, 2023 | -1.08 |
| Jun 30, 2023 | -0.98 |
| Mar 31, 2023 | -0.92 |
| Dec 31, 2022 | -0.93 |
| Sep 30, 2022 | -0.93 |
| Jun 30, 2022 | -0.07 |
| Mar 31, 2022 | -1.35 |
| Dec 31, 2021 | -1.02 |
| Sep 30, 2021 | -1.06 |